Generation of astrocytes from embryonic stem cells


Dateien zu dieser Ressource

Prüfsumme: MD5:769d9b9fdd38fd8dd1fb5f6839fc4f3c

KÜGLER, Philipp Balthasar, 2011. Generation of astrocytes from embryonic stem cells

@phdthesis{Kugler2011Gener-17434, title={Generation of astrocytes from embryonic stem cells}, year={2011}, author={Kügler, Philipp Balthasar}, address={Konstanz}, school={Universität Konstanz} }

2011-12-22T08:33:27Z Generation of astrocytes from embryonic stem cells Human exposure to chemicals by environmental pollution, food or drug constituents has been linked to developmental neurotoxicity (DNT) in epidemiological studies. In vitro models open up new possibilities to study toxicity on a molecular level, which is expected to improve human risk assessment. A starting point for the development of these models may be pluripotent stem cells as they can replicate development of an embryo in vitro.<br /><br />In this thesis, I discuss how DNT can be modelled in vitro using stem cell derived, differentiating neural cultures. Transcriptional profiling is suggested as a sensitive endpoint to detect toxic effects of substances. For this purpose, we developed comprehensive lists of marker genes for cells of different developmental stages within developing neural cultures. These were used to describe the effect of chemicals on embryonic stem cells (ESC) that differentiate to neurons.<br /><br />Until now, in vitro neurotoxicology has mainly focussed on neurons, the primary effector cells of the brain. However, other cells, such as astrocytes also play a role in generation of toxicity in the brain, either by causing an overshooting inflammatory response upon activation by pathogens or toxicants, or by metabolic activation of xenobiotics. At the start of this thesis, no protocols that described the generation of pure and functional astrocytes from ESC were known. Therefore, I developed two methods for the differentiation of mouse embryonic stem cell derived astrocytes (MEDA).<br /><br />The first method aimed at producing subtypes of astrocytes to study possible differences in astrocyte subpopulations. It relies on a 2-step protocol and yielded mixed subpopulations of astrocytes. While most cells (81 ± 16%) express the astrocyte marker S100β, only a subpopulation of these MEDA (31 ± 18 %) was positive for the standard astrocyte marker GFAP.<br /><br />With the second protocol, homogeneous astrocyte populations were obtained in very short time. ESC were first differentiated into pure populations of neural precursor cells. These precursor cells were then differentiated within 3-5 days to GFAP-positive MEDA. The fast transition into astrocytes makes them ideally suited for studies of developmental toxicity, as drugs interfering with astrocyte development can be picked up quickly.<br /><br />Both types of stem cell derived astrocytes were characterised in depth as to their inflammatory competence, metabolic activity, and their ability to provide trophic support to developing neuronal cultures. They were also compared to primary astrocytes isolated from mouse brain. To our knowledge, this work comprised the first functional characterisation of astrocyte subpopulations, and we found that GFAP-negative astrocytes contribute to inflammatory responses, and are able to support neurons in the same way as their GFAP-positive counterparts. In co-cultures with neurons, we found that MEDA were able to prolong neuronal survival. Furthermore, when plated on astrocytes, neurons grew at low cell-densities allowing single cell analysis of individual neurons. We propose that MEDA are an adequate alternative to primary isolated astrocytes.<br /><br />The new cell models generated during the course of this thesis are expected to be useful for research on brain disease and the development of novel test systems to detect (developmental) neurotoxicity.<br /> 2011 eng Kügler, Philipp Balthasar deposit-license Kügler, Philipp Balthasar 2013-12-13T23:25:05Z

Dateiabrufe seit 01.10.2014 (Informationen über die Zugriffsstatistik)

Diss_Kuegler.pdf 630

Das Dokument erscheint in:

KOPS Suche


Mein Benutzerkonto